Literature DB >> 29420696

Sensitivity Analyses for Misclassification of Cause of Death in the Parametric G-Formula.

Jessie K Edwards1, Stephen R Cole1, Richard D Moore2, W Christopher Mathews3, Mari Kitahata4, Joseph J Eron5.   

Abstract

Cause-specific mortality is an important outcome in studies of interventions to improve survival, yet causes of death can be misclassified. Here, we present an approach to performing sensitivity analyses for misclassification of cause of death in the parametric g-formula. The g-formula is a useful method to estimate effects of interventions in epidemiologic research because it appropriately accounts for time-varying confounding affected by prior treatment and can estimate risk under dynamic treatment plans. We illustrate our approach using an example comparing acquired immune deficiency syndrome (AIDS)-related mortality under immediate and delayed treatment strategies in a cohort of therapy-naive adults entering care for human immunodeficiency virus infection in the United States. In the standard g-formula approach, 10-year risk of AIDS-related mortality under delayed treatment was 1.73 (95% CI: 1.17, 2.54) times the risk under immediate treatment. In a sensitivity analysis assuming that AIDS-related death was measured with sensitivity of 95% and specificity of 90%, the 10-year risk ratio comparing AIDS-related mortality between treatment plans was 1.89 (95% CI: 1.13, 3.14). When sensitivity and specificity are unknown, this approach can be used to estimate the effects of dynamic treatment plans under a range of plausible values of sensitivity and specificity of the recorded event type.

Entities:  

Mesh:

Year:  2018        PMID: 29420696      PMCID: PMC6070049          DOI: 10.1093/aje/kwy028

Source DB:  PubMed          Journal:  Am J Epidemiol        ISSN: 0002-9262            Impact factor:   4.897


  30 in total

1.  When to start treatment? A systematic approach to the comparison of dynamic regimes using observational data.

Authors:  Lauren E Cain; James M Robins; Emilie Lanoy; Roger Logan; Dominique Costagliola; Miguel A Hernán
Journal:  Int J Biostat       Date:  2010       Impact factor: 0.968

2.  Bayesian perspectives for epidemiologic research: III. Bias analysis via missing-data methods.

Authors:  Sander Greenland
Journal:  Int J Epidemiol       Date:  2009-09-09       Impact factor: 7.196

3.  Invited commentary: positivity in practice.

Authors:  Daniel Westreich; Stephen R Cole
Journal:  Am J Epidemiol       Date:  2010-02-05       Impact factor: 4.897

4.  Accounting for misclassified outcomes in binary regression models using multiple imputation with internal validation data.

Authors:  Jessie K Edwards; Stephen R Cole; Melissa A Troester; David B Richardson
Journal:  Am J Epidemiol       Date:  2013-04-04       Impact factor: 4.897

5.  Validation data-based adjustments for outcome misclassification in logistic regression: an illustration.

Authors:  Robert H Lyles; Li Tang; Hillary M Superak; Caroline C King; David D Celentano; Yungtai Lo; Jack D Sobel
Journal:  Epidemiology       Date:  2011-07       Impact factor: 4.822

6.  The effect of diagnostic misclassification on non-cancer and cancer mortality dose response in A-bomb survivors.

Authors:  R Sposto; D L Preston; Y Shimizu; K Mabuchi
Journal:  Biometrics       Date:  1992-06       Impact factor: 2.571

7.  Initiation of Antiretroviral Therapy in Early Asymptomatic HIV Infection.

Authors:  Jens D Lundgren; Abdel G Babiker; Fred Gordin; Sean Emery; Birgit Grund; Shweta Sharma; Anchalee Avihingsanon; David A Cooper; Gerd Fätkenheuer; Josep M Llibre; Jean-Michel Molina; Paula Munderi; Mauro Schechter; Robin Wood; Karin L Klingman; Simon Collins; H Clifford Lane; Andrew N Phillips; James D Neaton
Journal:  N Engl J Med       Date:  2015-07-20       Impact factor: 91.245

8.  A Trial of Early Antiretrovirals and Isoniazid Preventive Therapy in Africa.

Authors:  Christine Danel; Raoul Moh; Delphine Gabillard; Anani Badje; Jérôme Le Carrou; Timothée Ouassa; Eric Ouattara; Amani Anzian; Jean-Baptiste Ntakpé; Albert Minga; Gérard M Kouame; Franck Bouhoussou; Arlette Emieme; Antoine Kouamé; André Inwoley; Thomas-d'Aquin Toni; Hugues Ahiboh; Mathieu Kabran; Cyprien Rabe; Baba Sidibé; Gustave Nzunetu; Romuald Konan; Joachim Gnokoro; Patrice Gouesse; Eugène Messou; Lambert Dohoun; Synali Kamagate; Abo Yao; Solange Amon; Amadou-Barenson Kouame; Aboli Koua; Emmanuel Kouamé; Yao Ndri; Olivier Ba-Gomis; Marcelle Daligou; Simplice Ackoundzé; Denise Hawerlander; Alex Ani; Fassery Dembélé; Fatoumata Koné; Calixte Guéhi; Constance Kanga; Serge Koule; Jonas Séri; Mykayila Oyebi; Nathalie Mbakop; Olewole Makaila; Carole Babatunde; Nathanael Babatounde; Gisèle Bleoué; Mireille Tchoutedjem; Alain-Claude Kouadio; Ghislaine Sena; Sahinou-Yediga Yededji; Rodrigue Assi; Alima Bakayoko; Alassane Mahassadi; Alain Attia; Armel Oussou; Max Mobio; Doféré Bamba; Mesmin Koman; Apollinaire Horo; Nina Deschamps; Henri Chenal; Madeleine Sassan-Morokro; Seidou Konate; Kakou Aka; Eba Aoussi; Valérie Journot; Célestin Nchot; Sophie Karcher; Marie-Laure Chaix; Christine Rouzioux; Papa-Salif Sow; Christian Perronne; Pierre-Marie Girard; Hervé Menan; Emmanuel Bissagnene; Auguste Kadio; Virginie Ettiegne-Traore; Corinne Moh-Semdé; Abo Kouame; Jean-Marie Massumbuko; Geneviève Chêne; Mireille Dosso; Serge K Domoua; Thérèse N'Dri-Yoman; Roger Salamon; Serge P Eholié; Xavier Anglaret
Journal:  N Engl J Med       Date:  2015-07-20       Impact factor: 91.245

9.  The parametric g-formula to estimate the effect of highly active antiretroviral therapy on incident AIDS or death.

Authors:  Daniel Westreich; Stephen R Cole; Jessica G Young; Frank Palella; Phyllis C Tien; Lawrence Kingsley; Stephen J Gange; Miguel A Hernán
Journal:  Stat Med       Date:  2012-04-11       Impact factor: 2.373

10.  When to initiate combined antiretroviral therapy to reduce mortality and AIDS-defining illness in HIV-infected persons in developed countries: an observational study.

Authors:  Lauren E Cain; Roger Logan; James M Robins; Jonathan A C Sterne; Caroline Sabin; Loveleen Bansi; Amy Justice; Joseph Goulet; Ard van Sighem; Frank de Wolf; Heiner C Bucher; Viktor von Wyl; Anna Esteve; Jordi Casabona; Julia del Amo; Santiago Moreno; Remonie Seng; Laurence Meyer; Santiago Perez-Hoyos; Roberto Muga; Sara Lodi; Emilie Lanoy; Dominique Costagliola; Miguel A Hernan
Journal:  Ann Intern Med       Date:  2011-04-19       Impact factor: 25.391

View more
  3 in total

1.  Gone But Not Lost: Implications for Estimating HIV Care Outcomes When Loss to Clinic Is Not Loss to Care.

Authors:  Jessie K Edwards; Catherine R Lesko; Michael E Herce; Gad Murenzi; Christella Twizere; Patricia Lelo; Kathryn Anastos; Olga Tymejczyk; Marcel Yotebieng; Denis Nash; Adebola Adedimeji; Andrew Edmonds
Journal:  Epidemiology       Date:  2020-07       Impact factor: 4.822

2.  A review of time scale fundamentals in the g-formula and insidious selection bias.

Authors:  Alexander P Keil; Jessie K Edwards
Journal:  Curr Epidemiol Rep       Date:  2018-06-15

Review 3.  A scoping review of studies using observational data to optimise dynamic treatment regimens.

Authors:  Maarten J IJzerman; Julie A Simpson; Robert K Mahar; Myra B McGuinness; Bibhas Chakraborty; John B Carlin
Journal:  BMC Med Res Methodol       Date:  2021-02-22       Impact factor: 4.615

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.